81vette
1年前
I am happy with chart,demand keeps coming when it goes down in 1.80s,1.76 is even bigger demand,went up after-mkt,i think in coming days many platforms will make it tradable and it will go up because of greed potential,my guess is they have news lined up to release,they sold that drug deal to Lilly in order to fund this bigger deal
81vette
1年前
VIVS,they say”reduce cost of approved drug by 50% across industry”if that is true, omg value and with fda pushing “phase out animal testing”
Not sure if holders from Onvo can sell yet,usually takes a week-10 days-some near a month before they can sell,just depends on platform,I have found a few like this with astonishing potential product that really fly,we shall see.this is just first day. Maybe someone with 100k followers pumps it soon.
Not financial advice just my greedy ranting opinion
PinkPennies
1年前
ONVO news .. Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
On February 23, 2025, Organovo Holdings, Inc., a Delaware corporation (the “Company”) entered into an asset purchase agreement (the “Purchase Agreement”) with Eli Lilly and Company, an Indiana corporation (“Lilly”). Pursuant to the Purchase Agreement, Lilly will purchase the Company’s FXR program and related assets (the “Asset Sale”) in consideration of (i) an upfront cash payment equal to $10.0 million, of which $9.0 million will be paid at closing and the remaining $1.0 million will be deposited into escrow for 15 months to satisfy any claims for indemnification under the Purchase Agreement, (ii) the assumption by Lilly of certain liabilities related to the FXR program, and (iii) potential milestone payments of up to $50.0 million in the aggregate, which are contingent upon the achievement of certain development, regulatory and commercial milestones. The Purchase Agreement contains customary representations, warranties and covenants for a transaction of this type. The Purchase Agreement also contains customary indemnification provisions pursuant to which the parties agree to indemnify each other for certain matters, including, among other things, breaches of certain representations, warranties and covenants in connection with the Asset Sale. Subject to the satisfaction or waiver of the closing conditions set forth in the Purchase Agreement, the Asset Sale is expected to close within approximately 30 days following the signing of the Purchase Agreement. In connection with the Asset Sale, the parties will also enter a transition services agreement and certain other ancillary agreements at the closing.
https://ih.advfn.com/stock-market/NASDAQ/organovo-ONVO/stock-news/95506537/organovo-s-fxr-program-including-fxr314-to-be-a
8k .. https://ih.advfn.com/stock-market/NASDAQ/organovo-ONVO/stock-news/95506518/form-8-k-current-report
phytokaiser1
3年前
From new 10Q. They dropped their burn rate a little more. Looking like 6 months of cash on hand starting Oct 1. They will need money before their new target data.
Date Cash Burn Rate
Friday, March 31, 2023 $15,301
Friday, June 30, 2023 $10,754 $4,547
Saturday, September 30, 2023 $7,617 $3,137